Quantcast

Latest Nerve Stories

2014-01-09 23:22:34

AxoGen Symposium to feature panel of renowned leaders in nerve repair Alachua, FL (PRWEB) January 09, 2014 AxoGen, Inc. (NASDAQ: AXGN), the only regenerative medicine company completely focused on peripheral nerve repair, today announced that it will sponsor a lunch symposium and panel discussion at the combined annual meetings of the American Association for Hand Surgery (AAHS), American Society for Peripheral Nerve (ASPN) and American Society for Reconstructive Microsurgery (ASRM)...

2014-01-06 23:03:04

Frost & Sullivan Innovation Award Highlights Significance of Avance® Nerve Graft for Peripheral Nerve Repair Alachua, FL (PRWEB) January 06, 2014 AxoGen, Inc. (NASDAQ: AXGN), the only regenerative medicine company completely focused on peripheral nerve repair, has been awarded the 2014 North American New Product Innovation Leadership Award for Peripheral Nerve Repair by the preeminent global research organization, Frost & Sullivan. The award is based on the findings of...

2014-01-06 08:25:56

AxoGen is the only regenerative medicine company that is completely focused on peripheral nerve repair MOUNTAIN VIEW, Calif., Jan. 6, 2014 /PRNewswire/ -- Based on its recent analysis of the peripheral nerve repair market, Frost & Sullivan recognizes AxoGen, Inc. with the 2013 North American Frost & Sullivan New Product Innovation Leadership Award for developing the Avance® Nerve Graft, a decellularized nerve allograft. Avance® Nerve Graft is the only commercially available...

2013-12-18 11:46:45

Fidgetin inhibition: Potential new therapeutic approach to promote tissue regeneration & repair of broken cell connections Suppressing the enzyme fidgetin promotes the re-growth of experimentally injured nerve cells and their connections, according to research with laboratory rats that will be presented Tuesday, Dec. 17, at the American Society for Cell Biology (ASCB) annual meeting in New Orleans. If additional studies confirm these results, fidgetin inhibition could be a potential...

2013-12-10 23:27:59

Partnership with City of Burleson to Support Growing Adoption of AxoGen’s Peripheral Nerve Repair Products Alachua, FL (PRWEB) December 10, 2013 AxoGen, Inc. (NASDAQ: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, and the City of Burleson, Texas, today announced that they have entered an agreement to support the opening of a new AxoGen distribution facility in Burleson. Under the city’s Economic Development Program, AxoGen will...

2013-11-14 23:03:34

Peripheral Nerve Repair Company demonstrates growth to qualify for Technology Fast 500™ List Alachua, FL (PRWEB) November 14, 2013 AxoGen, Inc. (NASDAQ: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, today announced it ranked 19th on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Karen Zaderej, Chief...

Clue To Regrowing Nerve Cells Identified
2013-11-07 12:54:44

Washington University School of Medicine Researchers at Washington University School of Medicine in St. Louis have identified a chain reaction that triggers the regrowth of some damaged nerve cell branches, a discovery that one day may help improve treatments for nerve injuries that can cause loss of sensation or paralysis. The scientists also showed that nerve cells in the brain and spinal cord are missing a link in this chain reaction. The link, a protein called HDAC5, may help...

2013-10-09 23:26:48

Company to feature portfolio of products for peripheral nerve repair, protection and regeneration at AAOMS Annual Meeting Alachua, FL (PRWEB) October 09, 2013 AxoGen, Inc. (NASDAQ: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, today announced the presentation of data on Avance® Nerve Graft at the American Association of Oral and Maxillofacial Surgeons (AAOMS) 95th Annual Meeting, taking place October 7-12 in Orlando, Florida....

2013-10-03 23:30:50

Includes updated data from RANGER® Registry and physician presentations on nerve repair with AxoGen products Alachua, FL (PRWEB) October 03, 2013 AxoGen, Inc. (NASDAQ: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, today announced the presentation of data on AxoGen’s Avance® Nerve Graft in four presentations, including updated data from the RANGER® Registry presented in a poster and podcast, at the American Society...

2013-10-01 23:26:41

Education events at ASSH 2013 to feature presentations by clinical experts who are redefining expectations for peripheral nerve repair and protection Alachua, FL (PRWEB) October 01, 2013 AxoGen, Inc. (NASDAQ: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, today announced that it will sponsor two educational forums at the American Society for Surgery of the Hand (ASSH) 2013 Meeting, taking place October 3-6 in San Francisco. Karen...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related